Assertio Holdings specializes in commercializing a portfolio of branded prescription pharmaceutical products tailored to distinct therapeutic segments. Over its operational history, its portfolio has included treatments for neurology conditions, pain management, and specialized hospital care products, alongside oncology supportive care treatments acquired through corporate expansion. The company utilizes a targeted digital commercialization and sales model to market these FDA-approved medications to healthcare professionals across the United States.